India, June 28 -- In a pathbreaking medical feat, a 17-year-old boy suffering from relapsed Neuroblastoma, an aggressive form of paediatric cancer, was given a new lease of life through an experimental nuclear therapy conducted at ACTREC (Advanced Centre for Treatment, Research and Education in Cancer), R&D wing of the Tata Memorial Centre in Navi Mumbai.

Doctors at the facility administered an ultra-high dose of radioactive 131-Iodine MIBG therapy, 800 millicurie, nearly three times the permissible limit set by the Atomic Energy Regulatory Board (AERB), making it the highest dosage ever used in India for treating Neuroblastoma. The procedure, conducted on May 5, was the result of a meticulously planned, three-month-long collaborative ef...